Edmonton Cardiology Consultants
Edmonton, Alberta T5H 4B9
1 studies enrolling now · 2 studies all time
What they study most
Atrial Fibrillation, Cardiovascular Disease, Prevention of Stroke or Systemic Embolism
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early